Focus Surgery, Inc.

Indianapolis, IN 46226
http://www.focus-surgery.com
14 Employees

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $3.02MM
First Award Date 09/15/00
Most Recent Award Date 08/21/09

Key Personnel

Last Name Name Awards Contact
Seip Ralf Seip 1
Lawler Casey Lawler 2 Message
Sanghvi Mr. Narendra T. Sanghvi 8 Message

9 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 08/21/09 - 07/31/11

DESCRIPTION (provided by applicant): Experimental investigations have demonstrated that the delivery of HIFU (High Intensity Focused Ultrasound) to cancerous tumors results in the release of heat shock proteins and generates a beneficial immune response. The release of proteins into the blood as a result of HIFU therapy is further demonstrated b...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 08/08/08 - 07/31/09

DESCRIPTION (provided by applicant): Experimental investigations have demonstrated that the delivery of HIFU (High Intensity Focused Ultrasound) to cancerous tumors results in the release of heat shock proteins and generates a beneficial immune response. The release of proteins into the blood as a result of HIFU therapy is further demonstrated b...

Phase 2 STTR

Institution: Sandia National Laboratories

Agency: Army
Topic: A05-T032
Budget: 10/05/06 - 03/04/09
PI: Ralf Seip

A low-risk, high-confidence, CSTAT-compatible HIFU hemostasis system that can be operated remotely was developed during Phase I to improve battlefield medicine to save lives. The system is based on a 23 channel annular HIFU phased array with a built-in co

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/27/06 - 08/28/07

DESCRIPTION (provided by applicant): Project Summary: Past experimental investigations have demonstrated that the application of HIFU (High Intensity Focused Ultrasound) to cancerous tumors results in the release of heat shock proteins and a beneficial immunizing effect. The release of proteins into the blood as a result of HIFU therapy is furth...

Phase 1 STTR

Institution: Sandia National Laboratories

Agency: Army
Topic: A05-T032
Budget: 07/13/05 - 01/17/06

It has been demonstrated that High Intensity Focused Ultrasound (HIFU) can be employed to rapidly and non-invasively induce hemostasis in severed, hemorrhaging organs. A need exists to use this technology in current and future Critical Systems for Trauma and Transport (CSTAT) systems to improve battlefield medicine to save lives. For this purpos...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/04 - 05/31/06

DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer death among American men, after lung cancer. Since early 1990s, Focus Surgery, Inc. (FSI) has developed and commercialized the Sonablate TM system, which makes use of a novel technology based on high intensity focused ultrasound (HIFU) for the minimally...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/03 - 05/31/04

DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer death among American men, after lung cancer. Since early 1990s, Focus Surgery, Inc. (FSI) has developed and commercialized the Sonablate TM system, which makes use of a novel technology based on high intensity focused ultrasound (HIFU) for the minimally...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/02 - 03/31/03

Description (provided by applicant): Electrocoagulation products such as the electrocautery knife and, more recently, the argon beam coagulator are ubiquitous; both employ thermal techniques for cauterizing small, severed blood vessels, as well as gross damage to the capillary bed. However, these devices are lar...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-99-149
Budget: 09/15/00 - 11/30/01

DESCRIPTION: (Applicant's Description) There is a resurgence of interest in the use of High Intensity Focused Ultrasound (HIFU) for various therapeutic applications. The development of the Sonablate TM 200 by Focus Surgery , Inc. for the treatment of Benign Prostatic Hyperpl...